Search

Your search keyword '"Bell, Joanne"' showing total 171 results

Search Constraints

Start Over You searched for: Author "Bell, Joanne" Remove constraint Author: "Bell, Joanne"
171 results on '"Bell, Joanne"'

Search Results

1. Clinical Meaningfulness in Alzheimer’s Disease Clinical Trials. A Report from the EU-US CTAD Task Force

3. Neuropsychiatric Symptoms in AD: Clinical Trials Targeting Mild Behavioral Impairment: A Report from the International CTAD Task Force

4. Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force

6. Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study

7. Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research.

8. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.

9. Postoperative continuous positive airway pressure to prevent pneumonia, re-intubation, and death after major abdominal surgery (PRISM): a multicentre, open-label, randomised, phase 3 trial

10. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need

11. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities

12. The TTP specialist nurse: an advocate for patients and professionals.

13. Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future.

16. Neuropsychiatric symptoms in Alzheimer's disease: Past progress and anticipation of the future

20. Microbial populations associated with treatment of an industrial dye effluent in an anaerobic baffled reactor

22. TREATMENT AND DECOLORIZATION OF DYES IN AN ANAEROBIC BAFFLED REACTOR

23. Indie beauty makes its mark

24. Additional file 1: of A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimerâ s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil

25. 34 The development of a framework to personalise hydration management in cancer care: the use of non-invasive technology to evaluate fluid status and dehydration-related symptoms

27. Health Staff Responses to Domestic and Family Violence: The Case for Training to Build Confidence and Skills.

29. P1-047: A Phase 2 Clinical Trial of PF-05212377 (SAM-760) in Subjects with Mild to Moderate Alzheimer's Disease with Existing Neuropsychiatric Symptoms on a Stable Daily Dose of Donepezil

33. The effect on lymphocyte subsets of decreasing/stopping tyrosine kinase inhibitor therapy in chronic myeloid leukaemia: data from the DESTINY trial.

34. A novel BACE inhibitor (PF-05297909): : A two-part adaptive design to evaluate safety, pharmacokinetics and pharmacodynamics for modifying beta-amyloid in a first-in-human study

36. Evaluating the use of plerixafor in stem cell mobilisation - an economic analysis of the PHANTASTIC trial.

38. P4-323: A comparison of crossover versus parallel-arm clinical study designs in evaluating the psychomotor and cognitive deficits induced by scopolamine

39. Computer art in an elementary school computer studio : how do students learn to develop computer art images?

40. P4‐253: Receptor occupancy of the 5‐HT6 receptor antagonist SAM‐760 in non‐human primates and healthy human volunteers

42. P4‐214: Single‐ and multiple‐dose safety, tolerability and pharmacokinetics of a Novel 5HT6 receptor full antagonist (SAM‐760) for the treatment of the symptoms of Alzheimer's disease in healthy young adults and elderly subjects

Catalog

Books, media, physical & digital resources